Evidence map›Paper›PMID 29898993›Full record

ArticleCancer research2018

Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics and Tumor Cell Movements.

Jae Ho Seo, Ekta Agarwal, Kelly G Bryant, M Cecilia Caino, Eui Tae Kim, Andrew V Kossenkov, Hsin-Yao Tang, Lucia R Languino, Dmitry I Gabrilovich, Andrew R Cohen and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Miro proteins and their role in mitochondrial transfer in cancer and beyond.Frontiers in cell and developmental biology · 2022
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jae Ho SeoProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania.
Ekta AgarwalProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania.
Kelly G BryantProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania.
M Cecilia CainoProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania.
Eui Tae KimDivision of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID 0000-0002-1631-3197
Andrew V KossenkovCenter for Systems and Computational Biology, The Wistar Institute, Philadelphia, Pennsylvania.
Hsin-Yao TangProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania.
Lucia R LanguinoProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania.
Dmitry I GabrilovichProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania.
Andrew R CohenDepartment of Electrical and Computer Engineering, College of Engineering, Drexel University, Philadelphia, Pennsylvania.
David W SpeicherProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania.
Dario C AltieriProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania. daltieri@wistar.org.
The Wistar Institute · USChildren's Hospital of Philadelphia · USDrexel University · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Role of Runx2 in prostate tumorigenesis and metastasisP01CA140043 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2010 to 2021
$12.2M
Tumor PlasticityR35CA220446 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2017 to 2023
$7.7M
Advancing Cancer Research through Comprehensive Proteomics and Metabolomics AnalysesR50CA221838 · NCI · WISTAR INSTITUTE · PI Hsin-Yao Tang · 2017 to 2026
$2.1M
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center LevelR50CA211199 · NCI · WISTAR INSTITUTE · PI Andrew V Kossenkov · 2016 to 2026
$1.6M
NCI NIH HHS P01 CA140043NCI NIH HHS P30 CA010815NCI NIH HHS R35 CA220446NCI NIH HHS R50 CA211199NCI NIH HHS R50 CA221838
6 · The paper itself

Abstract

Syntaphilin (SNPH) inhibits the movement of mitochondria in tumor cells, preventing their accumulation at the cortical cytoskeleton and limiting the bioenergetics of cell motility and invasion. Although this may suppress metastasis, the regulation of the SNPH pathway is not well understood. Using a global proteomics screen, we show that SNPH associates with multiple regulators of ubiquitin-dependent responses and is ubiquitinated by the E3 ligase CHIP (or STUB1) on Lys111 and Lys153 in the microtubule-binding domain. SNPH ubiquitination did not result in protein degradation, but instead anchored SNPH on tubulin to inhibit mitochondrial motility and cycles of organelle fusion and fission, that is dynamics. Expression of ubiquitination-defective SNPH mutant Lys111→Arg or Lys153→Arg increased the speed and distance traveled by mitochondria, repositioned mitochondria to the cortical cytoskeleton, and supported heightened tumor chemotaxis, invasion, and metastasis

Indexed as

AnimalsCell LineCell Line, TumorCell MovementCytoskeletonDynaminsHumansMaleMembrane ProteinsMiceMice, Inbred C57BLMitochondriaMitochondrial DynamicsNeoplasmsNerve Tissue ProteinsNIH 3T3 CellsDynaminsMembrane ProteinsNerve Tissue ProteinsSNPH protein, humanUbiquitin-Protein LigasesVesicular Transport Proteins

Identifiers

PMID29898993
PMCPMC6072605
OpenAlexW2807742671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.